

Get the latest on Aurovela Fe 1.5/30 28 Day availability in 2026. Learn about the current shortage status, why it's hard to find, and what you can do.
If you've been struggling to fill your Aurovela Fe 1.5/30 28 Day prescription, you're part of a growing number of patients running into the same problem. While birth control should be one of the easiest prescriptions to fill, the reality in 2026 is more complicated for certain generics — and Aurovela Fe 1.5/30 is one of them.
Here's what we know about the current situation, what's causing it, and what you can do about it.
As of March 2026, Aurovela Fe 1.5/30 28 Day is not officially listed on the FDA Drug Shortage Database. This means there is no formal, agency-recognized shortage for this specific medication.
However, the reality on the ground tells a different story. Many patients report difficulty finding Aurovela Fe 1.5/30 at their usual pharmacy. This is what's known as a "soft shortage" — the drug is technically being manufactured, but it's not consistently available at every pharmacy. The disconnect between the official list and patient experience is a well-known issue in pharmaceutical supply chains.
The broader category of Norethindrone Acetate/Ethinyl Estradiol combination oral contraceptives has seen supply fluctuations since 2023, and while the worst of the disruptions have eased, specific generic brands like Aurovela continue to have inconsistent availability depending on your location and pharmacy.
Several factors contribute to the difficulty:
Aurovela Fe 1.5/30 is made exclusively by Aurobindo Pharma. When a single manufacturer produces a product, any disruption — from quality control issues to raw material delays to routine maintenance shutdowns — directly impacts the entire supply of that brand.
There are many generic versions of Norethindrone Acetate/Ethinyl Estradiol 1.5/30 with iron (Junel Fe, Microgestin Fe, Larin Fe, Blisovi Fe, and more). Pharmacies can only stock so many brands, and their ordering systems often default to whichever generic their distributor offers at the lowest cost. If your insurance or prior prescription specifies Aurovela, you may find that your pharmacy simply doesn't carry it.
Pharmaceutical distributors allocate supply based on historical ordering patterns. If a pharmacy hasn't ordered Aurovela Fe 1.5/30 recently, they may receive a smaller allocation — or none — even when they try to order it. This creates a cycle where pharmacies that stock it continue to get it, and pharmacies that don't stock it struggle to obtain it.
When insurance companies change their preferred generic (which happens regularly), demand patterns shift rapidly. A pharmacy that was comfortably stocked with Aurovela Fe 1.5/30 may suddenly face higher demand, while another pharmacy may find its supply sitting unused. These transitions cause temporary, localized shortages. Learn more about why this drug is hard to find.
Cost varies depending on your insurance coverage and where you fill your prescription:
If cost is a concern, read our full guide to saving money on Aurovela Fe 1.5/30.
The oral contraceptive landscape continues to evolve. Here's what's relevant for Aurovela Fe 1.5/30 patients:
Here's a step-by-step approach:
For more detailed strategies, see our guide to finding Aurovela Fe 1.5/30 in stock.
The Aurovela Fe 1.5/30 28 Day situation in 2026 isn't a crisis, but it is a real inconvenience for many patients. The drug isn't in a formal FDA shortage, but soft supply issues and pharmacy stocking decisions mean you may need to put in extra effort to fill your prescription.
The most important thing: don't go without your birth control. Use the tools available to you — Medfinder, equivalent generics, independent pharmacies, and mail-order options — to make sure you stay on your medication. And if you're consistently having trouble, talk to your prescriber about switching to an alternative that's easier to find in your area.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.